12:00 AM
 | 
Mar 11, 2013
 |  BC Week In Review  |  Company News  |  Deals

Map Pharmaceuticals, Allergan deal

Allergan completed its acquisition of Map for $25 per share in cash. Allergan paid Map a...

Read the full 57 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >